Wen Yang

4.1k total citations · 1 hit paper
42 papers, 3.2k citations indexed

About

Wen Yang is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, Wen Yang has authored 42 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 11 papers in Cancer Research and 8 papers in Epidemiology. Recurrent topics in Wen Yang's work include Cancer, Hypoxia, and Metabolism (7 papers), Liver physiology and pathology (4 papers) and Wnt/β-catenin signaling in development and cancer (4 papers). Wen Yang is often cited by papers focused on Cancer, Hypoxia, and Metabolism (7 papers), Liver physiology and pathology (4 papers) and Wnt/β-catenin signaling in development and cancer (4 papers). Wen Yang collaborates with scholars based in China, United States and Taiwan. Wen Yang's co-authors include Hongyang Wang, Le‐Xing Yu, Mengchao Wu, Guishuai Lv, Hongwei Lv, Qin Han, Tian Fang, Linna Guo, Changzheng Wang and Liang Tang and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Wen Yang

41 papers receiving 3.2k citations

Hit Papers

Tumor-derived exosomal miR-1247-3p induces cancer-associa... 2018 2026 2020 2023 2018 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wen Yang China 24 2.0k 1.2k 887 457 432 42 3.2k
Ning Ren China 36 1.8k 0.9× 1.5k 1.2× 985 1.1× 707 1.5× 464 1.1× 113 3.7k
Kaishan Tao China 31 1.5k 0.8× 921 0.8× 646 0.7× 422 0.9× 283 0.7× 108 2.9k
Runqiu Jiang China 33 2.3k 1.2× 1.7k 1.4× 1.0k 1.2× 500 1.1× 818 1.9× 61 4.3k
Koichi Kawamoto Japan 35 2.3k 1.1× 1.7k 1.5× 1.4k 1.5× 373 0.8× 474 1.1× 164 4.2k
Catia Giovannini Italy 25 2.5k 1.3× 2.0k 1.6× 930 1.0× 312 0.7× 288 0.7× 52 3.6k
Guihua Chen China 29 1.7k 0.8× 910 0.8× 605 0.7× 240 0.5× 239 0.6× 85 3.2k
Limin Xia China 39 2.8k 1.4× 1.4k 1.1× 1.0k 1.1× 240 0.5× 356 0.8× 142 4.1k
Yiming Zhao China 31 1.4k 0.7× 679 0.6× 660 0.7× 145 0.3× 389 0.9× 102 2.9k
Maria Hatziapostolou United States 29 2.0k 1.0× 1.4k 1.2× 548 0.6× 162 0.4× 265 0.6× 52 3.2k
Rebecca T. Marquez United States 24 1.8k 0.9× 867 0.7× 481 0.5× 175 0.4× 417 1.0× 32 3.1k

Countries citing papers authored by Wen Yang

Since Specialization
Citations

This map shows the geographic impact of Wen Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen Yang more than expected).

Fields of papers citing papers by Wen Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wen Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen Yang. The network helps show where Wen Yang may publish in the future.

Co-authorship network of co-authors of Wen Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Wen Yang. A scholar is included among the top collaborators of Wen Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wen Yang. Wen Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chi, Xiaochun, Guangjun Wang, Wen Yang, et al.. (2025). Lian Qiao Wen Dan Decoction attenuates gastric carcinogenesis by alleviating oxidative phosphorylation dysfunction. Phytomedicine. 144. 156924–156924.
2.
Yang, Wen, Fahim Ebrahimi, Stefano Romeo, et al.. (2024). Risk of major adverse liver outcomes among first‐degree relatives of individuals with MASLD. Liver International. 44(5). 1253–1264. 2 indexed citations
3.
Lv, Guishuai, Wei Xiang, Yue Ma, et al.. (2023). Copper in hepatocellular carcinoma: A double-edged sword with therapeutic potentials. Cancer Letters. 571. 216348–216348. 31 indexed citations
4.
Ebrahimi, Fahim, Hannes Hagström, Jiangwei Sun, et al.. (2023). Familial coaggregation of MASLD with hepatocellular carcinoma and adverse liver outcomes: Nationwide multigenerational cohort study. Journal of Hepatology. 79(6). 1374–1384. 35 indexed citations
6.
Wang, Liang, Qingsong Jiang, Lan Chen, et al.. (2021). Ursolic acid inhibits multi-species biofilms developed by Streptococcus mutans, Streptococcus sanguinis, and Streptococcus gordonii. Archives of Oral Biology. 125. 105107–105107. 26 indexed citations
7.
Xu, Jing, Jiahui Wang, Xiaoli Wang, et al.. (2020). Soluble PD-L1 improved direct ARDS by reducing monocyte-derived macrophages. Cell Death and Disease. 11(10). 934–934. 23 indexed citations
8.
Zhang, Jun, et al.. (2018). Cytoglobin ameliorates the stemness of hepatocellular carcinoma via coupling oxidative‐nitrosative stress signals. Molecular Carcinogenesis. 58(3). 334–343. 9 indexed citations
9.
Fang, Tian, Hongwei Lv, Guishuai Lv, et al.. (2018). Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer. Nature Communications. 9(1). 191–191. 779 indexed citations breakdown →
10.
Wang, Changzheng, Hongwei Lv, Wen Yang, et al.. (2017). SVCT-2 determines the sensitivity to ascorbate-induced cell death in cholangiocarcinoma cell lines and patient derived xenografts. Cancer Letters. 398. 1–11. 36 indexed citations
11.
Wu, Fuquan, Tian Fang, Le‐Xing Yu, et al.. (2016). ADRB2 signaling promotes HCC progression and sorafenib resistance by inhibiting autophagic degradation of HIF1α. Journal of Hepatology. 65(2). 314–324. 179 indexed citations
12.
Zheng, Longyi, Wen Yang, Fuquan Wu, et al.. (2013). Prognostic Significance of AMPK Activation and Therapeutic Effects of Metformin in Hepatocellular Carcinoma. Clinical Cancer Research. 19(19). 5372–5380. 184 indexed citations
13.
Zou, Shan–Shan, Wen Yang, He‐Xin Yan, et al.. (2013). Role of β-Catenin in regulating the balance between TNF-α- and Fas-induced acute liver injury. Cancer Letters. 335(1). 160–167. 7 indexed citations
14.
Lin, Yan, Le‐Xing Yu, He‐Xin Yan, et al.. (2012). Gut-Derived Lipopolysaccharide Promotes T-Cell–Mediated Hepatitis in Mice through Toll-Like Receptor 4. Cancer Prevention Research. 5(9). 1090–1102. 33 indexed citations
15.
16.
Sun, Wen, Jin Ding, Kun Wu, et al.. (2011). Gankyrin-mediated dedifferentiation facilitates the tumorigenicity of rat hepatocytes and hepatoma cells. Hepatology. 54(4). 1259–1272. 48 indexed citations
17.
Ning, Beifang, Jin Ding, Chuan Yin, et al.. (2010). Hepatocyte Nuclear Factor 4α Suppresses the Development of Hepatocellular Carcinoma. Cancer Research. 70(19). 7640–7651. 194 indexed citations
19.
Yang, Wen, He‐Xin Yan, Lei Chen, et al.. (2008). Wnt/β-Catenin Signaling Contributes to Activation of Normal and Tumorigenic Liver Progenitor Cells. Cancer Research. 68(11). 4287–4295. 306 indexed citations
20.
Hung, Shih‐Chieh, et al.. (2004). Immortalization without neoplastic transformation of human mesenchymal stem cells by transduction with HPV16 E6/E7 genes. International Journal of Cancer. 110(3). 313–319. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026